Cytrellis Receives $50M Funding to Launch Ellacor, an FDA-Approved Aesthetic Device
Cytrellis announces the closing of a $50 million Series C funding round, in a news release.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
